Celldex Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $96M | 2.4M | 39.66 |
| 2023-09-30 | $52M | 1.9M | 27.52 |
| 2023-06-30 | $61M | 1.8M | 33.93 |
| 2023-03-31 | $65M | 1.8M | 35.98 |
| 2022-12-31 | $80M | 1.8M | 44.57 |
| 2022-09-30 | $51M | 1.8M | 28.11 |
| 2022-06-30 | $25M | 925k | 26.96 |